A recent study's results have shown that there is higher patient satisfaction with BioForm Medical Inc.'s Radiesse dermal filler than with either Juvederm or Perlane. This was established after this company conducted a new comparative study on patient satisfaction of nasolabial fold treatments. The results of this study, which was led by Marion Moers-Carpi, MD, Hautok, Munich, Germany, was published in the December 2007 Filler Issue of the Journal of Dermatologic Surgery.

Study Highlights
a. It was a 205-patient comparative study conducted at five clinical sites in Europe.
b. The aim of this study was to assess patient satisfaction and aesthetic improvement in treating nasolabial folds with Radiesse dermal filler as compared to Perlane and Juvederm.
c. Researchers injected less Radiesse filler than the hyaluronic acid fillers to achieve optimal results in this study.
d. Average total volume of Radiesse injected in two treatment sessions was 2.2cc, compared to 2.9cc of Perlane, 2.9cc of Juvederm 24HV and 4.8cc of Juvederm 24.
e. It was seen that at 12 months after the last injection, patient satisfaction was 90 per cent with Radiesse as compared to 48 per cent with Perlane and less than 10 per cent with the Juvederm group.
f. 93 per cent of patients also said that they were "likely" or "extremely likely" to return for future treatments with Radiesse against 38 per cent for Perlane and less than 10 per cent for the Juvederm group.
g. 94 per cent of Radiesse-treated patients said they would recommend Radiesse to others.

Conclusion
a. It was seen that there was higher patient satisfaction with Radiesse dermal filler.
b. It was also concluded that patients who received Radiesse were more likely to return for future treatments and recommend it to others.
c. Researchers concluded that Radiesse dermal filler has advantages like durability and cost besides having the other similar safety characteristics like hyaluronic acid fillers.